Jing Song Wang
Vorstandsvorsitzender bei HBM HOLDINGS LIMITED
Aktive Positionen von Jing Song Wang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FRONTAGE HOLDINGS CORPORATION | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - | |
HBM HOLDINGS LIMITED | Vorstandsvorsitzender | 20.07.2016 | - |
Vorsitzender | 20.07.2016 | - | |
Gründer | 20.07.2016 | - | |
XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD | Direktor/Vorstandsmitglied | 17.09.2021 | - |
Independent Dir/Board Member | 17.09.2021 | - | |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Vorstandsvorsitzender | - | - |
Vorsitzender | - | - | |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 01.08.2016 | - |
Independent Dir/Board Member | 01.08.2016 | - | |
Hbm Suzhou Co. Ltd. | Vorstandsvorsitzender | - | - |
Hbm Guangzhou | Vorstandsvorsitzender | - | - |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Direktor/Vorstandsmitglied | 01.06.2023 | - |
Independent Dir/Board Member | 01.06.2023 | - |
Karriereverlauf von Jing Song Wang
Ehemalige bekannte Positionen von Jing Song Wang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sanofi (China) Investment Co. Ltd. | Corporate Officer/Principal | 01.11.2011 | 01.12.2015 |
Ausbildung von Jing Song Wang
China Pharmaceutical University | Doctorate Degree |
Jilin University | Graduate Degree |
Xuzhou Medical University | Graduate Degree |
Statistik
International
China | 9 |
Cayman Islands | 4 |
Vereinigte Staaten | 2 |
Operativ
Chief Executive Officer | 4 |
Director/Board Member | 4 |
Independent Dir/Board Member | 4 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
FRONTAGE HOLDINGS CORPORATION | Health Technology |
HBM HOLDINGS LIMITED | Health Technology |
XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD | Commercial Services |
Private Unternehmen | 6 |
---|---|
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Health Technology |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Health Technology |
Hbm Suzhou Co. Ltd. | |
Hbm Guangzhou | |
Sanofi (China) Investment Co. Ltd. | |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Commercial Services |
- Börse
- Insiders
- Jing Song Wang
- Erfahrung